(Q57011695)

1

0 references

D Santini

2

0 references

M Gamberini

3

0 references

M Taffurelli

4

0 references

P Chieco

5

0 references

S Piana

6

0 references

S Pileri

7

0 references

D Marrano

8

0 references

Claudio Ceccarelli

1

0 references

Donatella Santini

2

0 references

Michela Gamberini

3

0 references

Mario Taffurelli

4

0 references

Pasquale Chieco

5

0 references

Simonetta Piana

6

0 references

Domenico Marrano

8

0 references

language of work or name

English

0 references

publication date

November 1999

0 references

number of pages

8

1 reference

Breast Cancer Research and Treatment

inferred from page(s)

published in

0 references

volume

58

0 references

issue

2

0 references

page(s)

107-14

0 references

107-114

0 references

exact match

https://scigraph.springernature.com/pub.10.1023/a:1006357524171

0 references

cites work

Neu and its ligands: from an oncogene to neural factors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Pattern of expression of c-erbB-2 oncoprotein in human fetuses

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

C-erbB-2 oncogene product expression depends on tumour type and is related to oestrogen receptor and lymph node status in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

c-erbB-2 oncogene as a prognostic marker in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Neu receptor dimerization

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Demonstration of cytokeratin intermediate filaments in oocytes of the developing and adult human ovary.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Antigen retrieval techniques in immunohistochemistry: comparison of different methods

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Optimization of immunohistochemical detection of ERBB2 in human breast cancer: impact of fixation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

Multiple expression patterns of biopathological markers in primary invasive breast carcinoma: a useful tool for elucidating its biological behaviour

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021

The neu-oncogene: more than a prognostic indicator?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006357524171

7 January 2021